Romiplostim 250 mcg is indicated for treating primary immune thrombocytopenia (ITP) in adult patients who are refractory to other therapies (corticosteroids, immunoglobulins). Treatment with romiplostim 250 mcg injection should remain under the apt supervision of a health specialist who is experienced in treating hematological diseases. The recommended dosage of Romiplostim 250 mcg should be administered once weekly as a subcutaneous injection. Romiplostim 250 mcg should not be used during pregnancy and in women of childbearing potential not using contraception.
Romiplostim has a moderate influence on the ability to drive and use machines. In clinical trials, mild to moderate, transient bouts of dizziness was reported by certain patients.
forum viewed 524,322 times
topics per page limited to: 5
average number of messages per page: 29
Copyright 1999 - 2021 www.curezone.com